Trial
NCT03540485
Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Collaborators
—
Condition
Sclerosis, Multiple
Intervention
Melatonin
Why stopped
Early termination due to operational feasibility reasons, resulting from a slow recruitment rate and logistical and financial difficulties that prevent reaching the planned sample size within the study schedule.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-20